Literature DB >> 7643487

Posterior sub-Tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema.

K Yoshikawa1, S Kotake, A Ichiishi, Y Sasamoto, S Kosaka, H Matsuda.   

Abstract

Repository corticosteroid was injected into the posterior sub-Tenon space in 29 cases (39 eyes) of cystoid macular edema (CME) secondary to uveitis. There were 12 cases of Behçet's disease, 7 cases of sarcoidosis, one case of tuberculous uveitis, and 9 cases of etiology unknown uveitis. In some of the patients injections were repeated 2 to 7 times at intervals of more than 2 weeks. Twenty-two of the 39 treated eyes (56.4%) showed visual improvement in at least two lines of visual acuity. Fifteen of the 22 eyes had maintained improved visual acuity over 6 months. Eleven eyes showed no improvement in vision. Most of them already had poor visual acuity (0.2 or less) before the injections. Complications of the treatment included cataract in 6 eyes, glaucoma in one, and blepharoptosis in one. Injection of repository corticosteroids into the posterior sub-Tenon space is of value in the treatment of CME secondary to uveitis. However, we have to beware of the complications of treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7643487

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  14 in total

1.  The effect of pars plana vitrectomy on cystoid macular oedema associated with chronic uveitis: a randomised, controlled pilot study.

Authors:  P Tranos; R Scott; H Zambarakji; H Zambarajki; W Ayliffe; C Pavesio; D G Charteris
Journal:  Br J Ophthalmol       Date:  2006-05-24       Impact factor: 4.638

2.  Trans-Tenon's retrobulbar injection of triamcinolone acetonide for diffuse diabetic macular edema.

Authors:  Mitsumasa Wada; Nahoko Ogata; Keizo Minamino; Masataka Koriyama; Akiko Higuchi; Miyo Matsumura
Journal:  Jpn J Ophthalmol       Date:  2005 Nov-Dec       Impact factor: 2.447

Review 3.  Management of uveitis in pediatric patients: special considerations.

Authors:  Justine R Smith
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

4.  Triamcinolone acetonide suppresses interleukin-1 beta-mediated increase in vascular endothelial growth factor expression in cultured rat Müller cells.

Authors:  Hirotaka Itakura; Hideo Akiyama; Norikazu Hagimura; Hiroshi Doi; Toru Tanaka; Shoji Kishi; Masahiko Kurabayashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-28       Impact factor: 3.117

5.  Medical treatment of macular edema in patients with uveitis.

Authors:  B Rojas; P Zafirakis; W Christen; N N Markomichelakis; C S Foster
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

6.  Corticosteroid eyedrops induced blepharoptosis and atrophy of levator muscle.

Authors:  Xiao Zhang; Mei-Fen Zhang; Da-Chun Zhao; Xiao-Wei Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-02-15       Impact factor: 3.117

7.  Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation.

Authors:  Zhenyu Dong; Kenichi Namba; Nobuyoshi Kitaichi; Chiho Goda; Mizuki Kitamura; Shigeaki Ohno
Journal:  Jpn J Ophthalmol       Date:  2008-11-11       Impact factor: 2.447

8.  Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections.

Authors:  Sung Jun Lee; Tyler Hyung Taek Rim; Sun Young Jang; Chan Yun Kim; Dong Yeob Shin; Eun Jig Lee; Sang Yeul Lee; Jin Sook Yoon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-12       Impact factor: 3.117

9.  Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis.

Authors:  A A Okada; T Wakabayashi; Y Morimura; S Kawahara; E Kojima; Y Asano; T Hida
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

10.  Periocular corticosteroid injections in uveitis: effects and complications.

Authors:  H Nida Sen; Susan Vitale; Sapna S Gangaputra; Robert B Nussenblatt; Teresa L Liesegang; Grace A Levy-Clarke; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; John H Kempen
Journal:  Ophthalmology       Date:  2014-07-11       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.